scholarly journals Blut : Blood Donation Application

Author(s):  
Sajith T ◽  
Santhose D ◽  
Senthalan S ◽  
Vasanth V

Blood Donation Management System is an android application that brings voluntary blood donors and those in need of blood on to a common platform. The mission is to fulfil every blood request in the country with a Promising android application and motivated individuals who are willing to donate blood. The proposed work aims to overcome the communication barrier between donors and receivers and aims to encourage people to donate blood by providing motivational videos and quotes in the app. This project will contain details about medical history of the donors and blood camps. We also aim to create misconceptions that people has regarding blood donation. This project aims at servicing the persons who seek donors who are willing to donate blood and also provide it in the time frame required. Blood Donation Management System tries to assist Victims/patients/those in want of blood. It is an endeavor to achieve dead set these people in want of blood and connect them to those willing to donate. The proposed work explores to find blood donors by using the blood group and address they have filled during registration

Author(s):  
Amrita S Kumar ◽  
A Geetha ◽  
Jim Joe ◽  
Arun Mathew Chacko

Introduction: Blood donation is one of the most significant contributions that a person can make towards the society. A donor generally donates maximum 450 mL of blood at the time of donation. If 450 mL of blood is taken in a donation, men lose 242±17 mg and women lose 217±11 mg of iron. Hence, adequate iron stores are very important in maintenance of the donor’s health. Aim: To assess the influence of frequency of blood donation on iron levels of blood donors by estimating Haemoglobin (Hb) and other blood indices which reflect iron status of blood and serum ferritin which reflects body iron stores. Materials and Methods: The present study was a cross-sectional analytical study, conducted on 150 blood donors, 18-40 years of age presenting to the Blood Bank in Government Medical College, Kottayam, Kerala, India, between December 2016 to December 2017. Total of 150 donors were divided into four groups according to the number of donations per year. Group I were the first time donors with no previous history of blood donation, Group II- included those with history of donation once in the previous year, Group III- those donors with history of donation twice in the previous year and Group IV- those having history of donation thrice in the previous year. Six ml of whole blood collected from each donor, two ml was used for estimating Haemoglobin (Hb), Packed Cell Volume (PCV), Mean Corpuscular Volume (MCV), Mean Corpuscular Hb (MCH), Mean Corpuscular Haemoglobin Concentration (MCHC) in haematology analyser. Serum separated from remaining four mL of blood underwent ferritin analysis by Chemiluminescence Immunoassay (CLIA) method. Iron stores were considered normal at serum ferritin value from 23.9-336ng/mL in males and 11-307ng/mL in females. Statistical analysis was performed in Statistical Package for the Social Sciences (SPSS) version 16.0. Analysis of Variance (ANOVA) test and Pearson correlation test were used to find association between various parameters and collected data. The p-value <0.05 was considered as statistically significant. Results: There was no significant correlation between serum ferritin level and frequency of blood donation. MCH, MCHC showed significant association (p-value 0.039 and 0.007, respectively) with frequency of blood donation. Low positive correlation was seen between Hb and PCV with serum ferritin levels (r=0.381, p-value <0.001 and r=0.354, p-value <0.001, respectively). Conclusion: There is no significant association between frequency of blood donation and serum ferritin levels.


2016 ◽  
Vol 15 (1) ◽  
pp. 66-69
Author(s):  
Kashfia Islam ◽  
Mazharul Hoque ◽  
Samsun Nahar ◽  
Syed Dawood Md. Taimur ◽  
Zeenat Farzana Rahman ◽  
...  

Background & Objective: Transfusion associated hepatitis B virus (TAHBV) infection continues to be a major problem despite mandatory screening for hepatitis B surface antigen (HBsAg). This is because HBsAg is not detected during the window period of the infection. This study was designed to assess the frequency of anti HBc antibody among HBsAg negative donor and also to determine the demographic profile of healthy blood donors.Material & Method: This cross sectional observational study was carried out in the Department of Transfusion Medicine, BSMMU, Dhaka during the period of May 2014 to April 2015. A total number of 100 consecutive healthy blood donors who were clinically and physically healthy and serologically found to be free from HBsAg, HCV and HIV by rapid chromographic test were included in this study.Results: Within the 100 patients among them history of jaundice was found in 17(17.0%). There all (100.0%) subjects had negative HBsAg and 14(14.0%) subjects had positive anti HBc-Ab. Anti HBc-Ab was statistically significant (p<0.001) in Z-test.Conclusion: This study was undertaken to assess the prevalence of anti HBc antibody among healthy blood donors with HBsAg negative in rapid chromatography method. The prevalence of anti HBc antibody was about 14 (14.0%) among 100 HBsAg negative blood donors. History of blood donation was found in almost two third 65 (65.0%). So, anti HBc antibody screening is an useful tool for estimating the risk of transfusion transmitted HBV infection.Bangladesh Journal of Medical Science Vol.15(1) 2016 p.66-69


Blood ◽  
2020 ◽  
Vol 136 (11) ◽  
pp. 1351-1358 ◽  
Author(s):  
Brian Custer ◽  
Claire Quiner ◽  
Richard Haaland ◽  
Amy Martin ◽  
Mars Stone ◽  
...  

Abstract Antiretroviral therapy (ART) to treat and pre-exposure prophylaxis (PrEP) to prevent HIV infection are effective tools to help end the HIV epidemic. However, their use could affect HIV transfusion-transmission risk. Three different ART/PrEP prevalence analyses in blood donors were conducted. First, blood samples from HIV-positive and a comparison group of infection-nonreactive donors were tested under blind using liquid chromatography-tandem mass spectrometry for ART. Second, blood donor samples from infection-nonreactive, 18- to 45-year-old, male, first-time blood donors in 6 US locations were tested for emtricitabine and tenofovir. Third, in men who have sex with men (MSM) participating in the 2017 Centers for Disease Control and Prevention National HIV Behavioral Surveillance (NHBS) from 5 US cities, self-reported PrEP use proximate to donation was assessed. In blind testing, no ART was detected in 300 infection-nonreactive donor samples, but in 299 HIV confirmed-infected donor samples, 46 (15.4%; 95% confidence interval [CI], 11.5% to 20.0%) had evidence of ART. Of the 1494 samples tested from first-time male donors, 9 (0.6%; 95% CI, 0.03% to 1.1%) had tenofovir and emtricitabine. In the NHBS MSM survey, 27 of 591 respondents (4.8%; 95% CI, 3.2% to 6.9%) reported donating blood in 2016 or 2017 and PrEP use within the same time frame as blood donation. Persons who are HIV positive and taking ART and persons taking PrEP to prevent HIV infection are donating blood. Both situations could lead to increased risk of HIV transfusion transmission if blood screening assays are unable to detect HIV in donations from infected donors.


Author(s):  
Ahana Bandyopadhyay ◽  
Ishita Kundu ◽  
Anwita Chakraborty ◽  
Rajat Kumar ◽  
Ayush Kumar ◽  
...  

2018 ◽  
Vol 143 (1) ◽  
pp. 130-134 ◽  
Author(s):  
Tatiana Villatoro ◽  
Julie Katz Karp

Babesiosis is most commonly caused by Babesia microti and is transmitted via the bite of an infected Ixodes spp tick. However, Babesia is also transmitted via blood transfusion. In the United States, the first case of transfusion-transmitted babesiosis was recognized in 1979, and in recent years, the incidence has rapidly increased. Because most of the infected blood donors do not experience any symptoms, they pose a significant risk to the blood supply. Donor deferral for a history of babesiosis is currently performed but is ineffective. In March 2018, the FDA licensed a DNA PCR and antibody assay that were used in tandem in pivotal trials for screening blood donors for B microti; with other assays still being evaluated under investigational new drug protocols. Blood donation screening is essential to reducing the risk of transfusion-transmitted babesiosis, which is why blood centers collecting in geographic regions of highest risk have been testing since approximately 2010. Investigational NAT assays of higher sensitivity are pending FDA review. Further, in July 2018, the FDA issued a draft guidance for reducing the risk of transfusion-transmitted babesiosis. Release of the final guidance may be postponed until sensitivities and specificities of all current and potential strategies have been properly evaluated.


Author(s):  
Garima Vijayvergiya ◽  
Parag Fulzele ◽  
Naveen Vairyamoorthy

Background: Despite the advent of many synthetic and semi-synthetic products, the importance of biological blood products cannot be undermined in the current era. The blood donors are the backbone of any health care delivery system that has a well-organized blood transfusion service.Methods: A prospective study conducted for the period of 16 months aimed to find out various complications and their frequencies before, during or after the blood donations. The donors who developed any complications were followed up for at least three weeks to assess the late reactions if any. Blood donation was carried out with proper precautions and asepsis by experienced phlebotomists.Results: Out of 10346 blood donations, 9887 were from replacement donors, while 459 were from voluntary donors. Total donation associated complications were 113, out of which the majority were VVRs (n=74), followed by venous hematomas (n=34) and arterial punctures (n=5). Of the 74 donors who had a VVR after blood donation, the incidence was higher in females (1.64% versus 0.69%). A higher incidence of VVRs was seen among the donors who had a history of previous blood donation.Conclusions: This study strengthened the fact that though blood donation is relatively safe, it still has a complication rate of nearly 1%. To encourage for blood donation at a regular interval, all the possible steps should be taken to minimize the rate of complications. More medical attention should be given to the “at-risk” donors.


2018 ◽  
Vol 12 (10) ◽  
pp. 2766
Author(s):  
Luciana Martins da Rosa ◽  
Rosane Suely May Rodrigues ◽  
Rosane Gonçalves Nitschke ◽  
Rafaela Dutra Nunes da Silva ◽  
Jussara Cargnin Ferreira ◽  
...  

RESUMO Objetivo: revelar o discurso do sujeito coletivo sobre a história da captação de doadores e da doação de sangue. Método: trata-se de estudo qualitativo, exploratório e descritivo, por meio de entrevistas semiestruturadas, transcritas e validadas, com 18 profissionais atuantes nas áreas de hematologia e hemoterapia. Organizaram-se as comunicações e as analisaram pela técnica do Discurso do Sujeito Coletivo. Resultados: emergiram-se a partir dos discursos duas ideias centrais “Captação de doadores de sangue: da doação remunerada à espontânea” e “Informação e educação transformando a cultura da doação”. Conclusão: tornaram-se a tônica da captação de doadores a informação e a educação no recorte de tempo investigado, contribuindo para a transformação da cultura da doação de sangue. Descritores: História; Serviço de Hemoterapia; Saúde; Atividades Cotidianas; Doadores de Sangue; Discursos.ABSTRACTObjective: to reveal the discourse of the collective subject on the history of donor recruitment and blood donation. Method: this is a qualitative, exploratory and descriptive study, using semi-structured, transcribed and validated interviews, with 18 professionals working in the areas of hematology and hemotherapy. The communications were organized and analyzed by the technique of the Discourse of the Collective Subject. Results: two central ideas emerged from the discourses: "Funding of blood donors: from donated to spontaneous donation" and "Information and education transforming the culture of donation". Conclusion: the focus of donor recruitment has been on information and education in the time cut investigated, contributing to the transformation of blood donation culture. Descriptors: History; Hemotherapy Service; Health; Activities of Daily Living; Blood Donors; Addresses.RESUMENObjetivo: revelar el discurso del sujeto colectivo sobre la historia de la captación de donantes y de la donación de sangre. Método: se trata de un estudio cualitativo, exploratorio y descriptivo, por medio de entrevistas semiestructuradas, transcritas y validadas, con 18 profesionales actuantes en las áreas de hematología y hemoterapia. Se organizaron las comunicaciones y las analizaron por la técnica del Discurso del Sujeto Colectivo. Resultados: surgieron a partir de los discursos dos ideas centrales "Captación de donantes de sangre: de la donación remunerada a la espontánea" e "Información y educación transformando la cultura de la donación". Conclusión: se convirtió en la tónica de la captación de donantes a la información y la educación en el recorte de tiempo investigado, contribuyendo a la transformación de la cultura de la donación de sangre. Descriptores: Historia; Servicio de Hemoterapia; Salud; Actividades Cotidianas; Donantes de Sangue; Discursos.


2021 ◽  
pp. 1-8
Author(s):  
May Raouf ◽  
Mariem Rabeh ◽  
Suminder Kaur ◽  
Ranjita Sharma ◽  
Nimmy Thottumkal ◽  
...  

<b><i>Background and Objectives:</i></b> During the pandemic of CO­VID-19, additional blood donor eligibility criteria have been added to ensure safety of donors and donations. The aim of this study is to estimate the seroprevalence of SARS-CoV-2 antibody in eligible donors and to study the demography and lifestyle of asymptomatic cases. <b><i>Materials and Methods:</i></b> One thousand four hundred eighteen eligible donors were enrolled in this study in the Dubai Blood Donation Center from August to December 2020. Blood samples were tested for SARS-CoV-2 antibody. Donors’ demographic characteristics and lifestyle were studied further. The χ<sup>2</sup> test was used to analyze the data association. <b><i>Results:</i></b> 88.4% of the studied group were males, 85% were from age 17 to 45 years, and 53% were regular donors. The seroprevalence of SARS-CoV-2 antibody was 13.5% and significantly related to gender, frequency of donation, collection site, type of donation, and more frequent when donors shared transport and accommodation. Blood group and age had no significant association. 5.5% were found to have cough/fever or a history of contact with positive COVID-19 patients. <b><i>Conclusions:</i></b> The seroprevalence of SARS-CoV-2 antibody was 13.5% among eligible blood donors, and hence the current eligibility criteria allow asymptomatic COVID-19 patients to donate blood. The seroprevalence was seen more in first time donors, suggesting that regular blood donors are safer. Additional risk factors related to lifestyle can be identified to ensure safety of transfusion during COVID-19 pandemic.


Author(s):  
Atik Dina Naseha ◽  
Nur’Aini Purnamaningsih ◽  
Kuswanto Hardjo

At the end of 2019, it was found that there was a very fast mutating virus called the Covid-19 virus, this virus causes diseases ranging from coughs to colds to death, efforts to prevent the spread of this virus by limiting the social scale of the community which causes a decrease in the number of blood donors which has an impact on the amount of blood stock in Blood Donation Unit. The objective of this study was to determine the description of blood donors based on blood type, gender, age, and type of donor at Blood Donation Unit Bantul Regency in 2020. This study was an activity report by observing secondary data obtained from Blood Donation Unit Bantul Regency. The number of donors was 8.212 donors, of which the number of donations from inside the building was 5.936 donors (72,28%), and the number of donations from mobile units was 2.276 donors (27,72%). The results showed that the majority of blood donors were blood group 0, which was 3.506 (42,69%), and the least blood type was AB, which was 468 (5.70%). The majority of the gender of the donor was male, namely 7.020 (85,48%), for female, 1.192 (14,52%). The majority of donors are aged 17-24 years, namely 1.738 (21,16%), and at least 65 years old 45 (0,55%). The majority of voluntary donors were 5.151 (62,73%), and the subtitute/ family donors were 1.034 (12,59%). There were 8.212 blood donors where the majority of blood group 0 was 3.506 (42,69%), male sex was 7.020 (85,48%), in the 17-24 year age group 1.738 (21,16%), and repeated voluntary donors were 5.151 (62,73%).


2011 ◽  
Vol 44 (3) ◽  
pp. 269-273 ◽  
Author(s):  
Luciana da Silveira ◽  
Leonardo de Lucca Schiavon ◽  
Kerley Pereira da Silva ◽  
Thiago Barbieri Lopes ◽  
Marcos da Rocha Zaccaron ◽  
...  

INTRODUCTION: Positive serological tests for hepatitis viruses B and C at blood banks are an important reason for blood deferral. Additionally, high residual risk for transfusing hepatitis-contaminated blood has been estimated in southern Brazil. This study aimed to identify risk factors for positive serological tests for viral hepatitis (VH) in blood donors (BD). METHODS: A case-control study included consecutive BD with positive serology for VH, between 2008 and 2009. Cases and controls (BD with negative serology for VH) were paired 1:1 by sex and donation date. Assessment of clinical and epidemiological characteristics related to viral hepatitis was conducted. RESULTS: Among 1,282 blood donors (641 cases and 641 controls), those with positive serology for viral hepatitis had higher mean age (p<0.001); higher proportion of replacement donation (p<0.001); first donation (p<0.001); and interviewer deferment (p=0.037), compared to controls. Furthermore, donors with positive tests were less regular donors (p<0.001), had less previous history of rejection (p=0.003) and showed lower hematocrit median before donation (p=0.019). Multivariate analysis demonstrated that age (OR=1.056, 95%CI 1.042-1.069, p<0.001), replacement donation (OR=1.545, 95%CI 1.171-2.038, p=0.002) and first donation (OR=9.931, 95%CI 7.486-13.173, p<0.001) were independently associated with positivity of serological tests for viral hepatitis. CONCLUSIONS: Specific characteristics of blood donors were associated with positive serology for viral hepatitis. These peculiarities should be taken into account when assessing candidates for blood donation.


Sign in / Sign up

Export Citation Format

Share Document